BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11104564)

  • 1. Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.
    Austrup F; Uciechowski P; Eder C; Böckmann B; Suchy B; Driesel G; Jäckel S; Kusiak I; Grill HJ; Giesing M
    Br J Cancer; 2000 Dec; 83(12):1664-73. PubMed ID: 11104564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation in plasma DNA and its prognostic value in breast cancer patients.
    Shao ZM; Wu J; Shen ZZ; Nguyen M
    Clin Cancer Res; 2001 Aug; 7(8):2222-7. PubMed ID: 11489795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
    Geisler S; Lønning PE; Aas T; Johnsen H; Fluge O; Haugen DF; Lillehaug JR; Akslen LA; Børresen-Dale AL
    Cancer Res; 2001 Mar; 61(6):2505-12. PubMed ID: 11289122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
    Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
    Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.
    Scorilas A; Trangas T; Yotis J; Pateras C; Talieri M
    Br J Cancer; 1999 Dec; 81(8):1385-91. PubMed ID: 10604737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
    Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
    Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
    Ke F; Wu JM; Yao JE; Bai YJ; Guo AL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2257-61. PubMed ID: 18001545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of sequential genetic alterations relevant for breast cancer development.
    Niederacher D; Schnürch HG; An HX; Ellenberger I; Dall P; van Roeyen CR; Küppers V; Beckmann MW
    Eur J Cancer Prev; 1996 Dec; 5(6):497-503. PubMed ID: 9061283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
    Silva JM; Silva J; Sanchez A; Garcia JM; Dominguez G; Provencio M; Sanfrutos L; Jareño E; Colas A; España P; Bonilla F
    Clin Cancer Res; 2002 Dec; 8(12):3761-6. PubMed ID: 12473587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.
    Climent J; Martinez-Climent JA; Blesa D; Garcia-Barchino MJ; Saez R; Sánchez-Izquierdo D; Azagra P; Lluch A; Garcia-Conde J
    Clin Cancer Res; 2002 Dec; 8(12):3863-9. PubMed ID: 12473601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number of cancer genes predict tumor grade and survival of pancreatic cancer patients.
    Nagy A; Kozma L; Kiss I; Ember I; Takacs I; Hajdu J; Farid NR
    Anticancer Res; 2001; 21(2B):1321-5. PubMed ID: 11396207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.